Alexza Pharmaceuticals (ALXA) Gains After Results

Alexza Pharmaceuticals, Inc.

shares climbed 4.5% to 91.74 cents after the company reported interim results from Phase 2a study of AZ-002 in epilepsy patients. Share volume totaled 1.8 million, dwarfing an all-day average of 7,900